Literature DB >> 15522216

Studying protein isoforms of the adaptor SETA/CIN85/Ruk with monoclonal antibodies.

Susan Finniss1, Ashley Movsisyan, Christine Billecke, Mirko Schmidt, Lisa Randazzo, Baihua Chen, Oliver Bögler.   

Abstract

SETA/CIN85/Ruk is a multifunctional adaptor protein involved in signal transduction and attenuation downstream of receptor tyrosine kinases. It has a modular structure, and various isoforms that combine different protein-protein interaction domains have been proposed based on cDNA analysis. As a first step towards understanding SETA/CIN85/Ruk isoforms at the protein level, we have characterized 5 monoclonal antibodies against this protein. Three of these were used to study lysates fractionated on a pH gradient, leading to the identification of various SETA/CIN85/Ruk proteins on the basis of pI and apparent molecular weight. While good correspondence with proteins predicted from cDNA analysis was found for two isoforms, in most cases it was not possible to make an unequivocal assignment. We conclude that additional splice variants remain to be described, and that a deeper understanding of SETA/CIN85/Ruk post-translational processing and modification is necessary to gain further understanding of this complex gene product.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522216     DOI: 10.1016/j.bbrc.2004.10.007

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  CIN85 interacting proteins in B cells-specific role for SHIP-1.

Authors:  Tom Büchse; Nikolaus Horras; Eva Lenfert; Gerald Krystal; Sandra Körbel; Michael Schümann; Eberhard Krause; Stefan Mikkat; Markus Tiedge
Journal:  Mol Cell Proteomics       Date:  2011-07-01       Impact factor: 5.911

2.  CIN85 regulates dopamine receptor endocytosis and governs behaviour in mice.

Authors:  Noriaki Shimokawa; Kaisa Haglund; Sabine M Hölter; Caroline Grabbe; Vladimir Kirkin; Noriyuki Koibuchi; Christian Schultz; Jan Rozman; Daniela Hoeller; Chun-Hong Qiu; Marina B Londoño; Jun Ikezawa; Peter Jedlicka; Birgit Stein; Stephan W Schwarzacher; David P Wolfer; Nicole Ehrhardt; Rainer Heuchel; Ioannis Nezis; Andreas Brech; Mirko H H Schmidt; Helmut Fuchs; Valerie Gailus-Durner; Martin Klingenspor; Oliver Bogler; Wolfgang Wurst; Thomas Deller; Martin Hrabé de Angelis; Ivan Dikic
Journal:  EMBO J       Date:  2010-06-15       Impact factor: 11.598

3.  A Novel Interaction of the Catalytic Subunit of Protein Phosphatase 2A with the Adaptor Protein CIN85 Suppresses Phosphatase Activity and Facilitates Platelet Outside-in αIIbβ3 Integrin Signaling.

Authors:  Tanvir Khatlani; Subhashree Pradhan; Qi Da; Tanner Shaw; Vladimir L Buchman; Miguel A Cruz; K Vinod Vijayan
Journal:  J Biol Chem       Date:  2016-06-22       Impact factor: 5.157

4.  Inhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide.

Authors:  Seiichi Sato; Yingshe Zhao; Misa Imai; Philip C Simister; Stephan M Feller; Philip C Trackman; Kathrin H Kirsch; Gail E Sonenshein
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

5.  CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes.

Authors:  Beina Teng; Patricia Schroder; Janina Müller-Deile; Heiko Schenk; Lynne Staggs; Irini Tossidou; Ivan Dikic; Hermann Haller; Mario Schiffer
Journal:  Diabetes       Date:  2016-08-16       Impact factor: 9.461

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.